Á¿×Ó×ÊÔ´Íø

This webinar is designed for life sciences companies seeking to navigate the New Technology Add-on Payment (NTAP) program. This session will equip drug, device, and diagnostic manufacturers with a clear understanding of eligibility requirements, the application process, and how to strategically position products for approval. Experts from Á¿×Ó×ÊÔ´Íø and Manatt Health will also break down CMS evaluation criteria and highlight key updates shaping the NTAP program in 2026 and 2027.

Learning Objectives:

• Understand NTAP eligibility requirements and the end-to-end application process
• Learn how CMS evaluates applications and what drives approval decisions
• Explore key updates and policy changes impacting NTAP in 2026 and 2027

Speakers:

• Clare Mamerow, Principal, Á¿×Ó×ÊÔ´Íø
• Ross Margulies, Partner, Manatt Health